Atovaquone: a new oral treatment for pneumocystis.
D000935:Antifungal Agents / Q000627:therapeutic use*; D053626:Atovaquone; D001682:Biological Availability; D016527:Drug Costs; D006801:Humans; D009285:Naphthoquinones / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D011020:Pneumonia, Pneumocystis / Q000188:drug therapy*
D000935:Antifungal Agents; D009285:Naphthoquinones; D053626:Atovaquone